The Biospecimen Core of the COBRE, established by the Phase I of this COBRE, is to provide well-preserved and properly annotated biospecimen such as tissue and blood components to the COBRE investigators and other cancer researchers in the Stephenson Cancer Center of the University of Oklahoma. Data management services of the core provides standardized annotations using a secure database system. The Core also supports the investigators in the conception of prospective specimen collection protocols and specimen analysis to minimize the effect of pre-analytic and analytic variables on study results. In conjunction with the Histology, Immunochemistry, and Microscopy Core of the COBRE, histologic quality control will be ensured by board- certified pathologists. In addition, the core provides tissue processing services including the preparation of formalin-fixed paraffin-embedded (FFPE) and optimal cutting temperature (OCT) embedded tissue blocks for subsequent histopathological analysis. To assist cancer researchers in carrying out high-throughput molecular profiling studies in cancer, the core provides tissue microarray construction service. During the Phase I COBRE funding period, 4 PJIs, 3 PPIs, and 69 non-COBRE investigators have used this core with resulting in several grant applications and peer-reviewed publications. Under Phase II of this COBRE, the Biospecimen Core will strive to continue its mission in providing high quality biospecimens to COBRE investigators as well as to the greater community of cancer researchers in Oklahoma. This will be accomplished under three specific aims. They are: 1. Provide annotated human biospecimens including tissues and blood components, 2. Aid in the design and implementation of prospective specimen collection protocols, and 3. Construct tissue microarrays tailored to individual and collaborative research projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
2P20GM103639-06A1
Application #
9573533
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Jaiprasart, Pharavee; Yeung, Bertrand Z; Lu, Ze et al. (2018) Quantitative contributions of processes by which polyanion drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex. J Control Release 270:101-113
Buechel, Megan; Dey, Anindya; Dwivedi, Shailendra Kumar Dhar et al. (2018) Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther 17:2136-2143
Ha, Ji Hee; Radhakrishnan, Rangasudhagar; Jayaraman, Muralidharan et al. (2018) LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Res 78:1923-1934
Dey, Anindya; Xiong, Xunhao; Crim, Aleia et al. (2018) Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther 17:39-49
Boswell-Casteel, Rebba C; Johnson, Jennifer M; Roe-Žurž, Zygy et al. (2018) Expression and purification of human and Saccharomyces cerevisiae equilibrative nucleoside transporters. Protein Expr Purif 142:68-74
Jiao, Yang; Watts, Tanya; Xue, Jing et al. (2018) Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. BMC Cancer 18:1042
Sun, X; Ren, Y; Gunawan, S et al. (2018) Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia 32:1246-1249
Amreddy, Narsireddy; Babu, Anish; Panneerselvam, Janani et al. (2018) Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine 14:373-384
Liu, Xuan; Shen, Tao; Mooers, Blaine H M et al. (2018) Drug resistance profiles of mutations in the RET kinase domain. Br J Pharmacol 175:3504-3515
Boswell-Casteel, Rebba C; Johnson, Jennifer M; Hays, Franklin A (2018) Functional Characterization of the Saccharomyces cerevisiae Equilibrative Nucleoside Transporter 1 (ScENT1). Molecules 23:

Showing the most recent 10 out of 68 publications